Moreover, the differentially expressed genes (DEGs) analysis revealed that Sumo2 was significantly up-regulated in residual tumor following iRFA in HCC (Fig. 1B, C, Figure S4). This evidence concerns the gene SUMO2 and hepatocellular carcinoma.